A study showing that follicular lymphoma patients benefit from adding interferon to standard chemotherapy has opened up new avenues for research.
Follicular lymphoma: side-lined drug excites new interest
Janet Fricker
Related Articles
Impact Factor
Rituximab for follicular lymphoma: maintaining an open mind
Impact Factor
Is rituximab maintenance therapy useful following rituximab salvage in refractory or relapsed follicular lymphoma?
Senza categoria
Leave a Reply